2008 Jul;22(4):1130-5
Blogs & News
Why does this matter
By helping patients lose a significant amount of weight, Zepbound can reduce the physical pressure on the airway , improve oxygenation during sleep, and in some cases reduce the severity of sleep apnea to the point that traditional devices are no longer necessary
A 68-week trial published in the New England Journal of Medicine showed that participants taking semaglutide lost an average of 14% of their body weight, compared to a 3% loss in the placebo group
OCR was recorded three times under basal conditions and three times after the addition of Mito Stress compounds (Mito Stress Test Kit, Agilent, Santa Clara, California, USA): oligomycin (oligo, 1 M, adenosine triphosphate (ATP)-synthase inhibitor), fluorocarbonyl cyanide phenylhydrazone (FCCP, 0.5 M, decoupler), and rotenone/antimycin A (rot/AA, 0.5 M, complex 3/1 inhibitor), as shown in Figure 1